Stories indexed with the term ‘Michigan Advanced Development and Manufacturing Center’

An operating agreement for the Michigan Advanced Development and Manufacturing Center (MADMC) was amended by the University of Michigan board of regents at its Sept. 20, 2012 meeting. According to a staff memo, the change aims to ”provide potential MADMC leadership candidates with the level of management independence and operational flexibility needed to effectively direct a manufacturing start-up enterprise.” The memo states that MADMC is pursuing “contractual opportunities that would utilize the assets at NCRC.” The NCRC is the North Campus Research Complex, which the university bought from Pfizer in 2009.

MADMC has been a low-profile venture, and hasn’t been explicitly discussed by the regents. Formed in March of 2012, it was created by UM to seek a U.S. Dept. of Defense … [Full Story]

The University of Michigan board of regents authorized 11 items that required disclosure under the state’s conflict-of-interest statute, in votes taken at the board’s July 19, 2012 meeting. The law requires that regents vote on potential conflict-of-interest disclosures related to university staff, faculty or students.

Among them was an item related to consulting in support of a pharmaceutical manufacturing facility at the North Campus Research Complex (NCRC). That project is the Michigan Advanced Development and Manufacturing Center – an entity created by UM to seek a U.S. Dept. of Defense contract to develop pharmaceutical manufacturing at the former Pfizer site. At this point, the conflict-of-interest item is a retroactive disclosure of consulting services with NanoBio Corp. from Feb. 10, 2012, through June 30, 2012, with a … [Full Story]